Purchases and Sales Made in Q2 2024 in Vor Biopharma Inc. (VOR)
This table provides information about the institutional ownership of Vor Biopharma Inc. (VOR) during Q2 2024. The information is specifically focused on institutions that hold shares of Vor Biopharma Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2024
Q2 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-12.7K- 33.07% |
$12.7K - $28K
|
25.8K
$36.1K
|
|
|
Aug 12, 2024
Q2 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-15.2K- 93.93% |
$15.2K - $33.4K
|
983
$1.38K
|
|
|
Aug 14, 2024
Q2 2024
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-17.6K- 4.42% |
$17.6K - $38.8K
|
381K
$533K
|
|
|
Jul 31, 2024
Q2 2024
|
New York State Common Retirement Fund
|
SELL
|
- |
-21.5K- 98.53% |
$21.5K - $47.4K
|
322
$451
|
|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
SELL
|
- |
-27.2K- 70.82% |
$27.2K - $59.8K
|
11.2K
$15.7K
|
|
|
Aug 13, 2024
Q2 2024
|
Exchange Traded Concepts, LLC
|
SELL
|
- |
-36.6K- 23.73% |
$36.6K - $80.6K
|
118K
$165K
|
|
|
Aug 01, 2024
Q2 2024
|
Rhumbline Advisers
Boston, MA |
SELL
|
- |
-38.2K- 87.39% |
$38.2K - $84K
|
5.51K
$7.71K
|
|
|
Aug 12, 2024
Q2 2024
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-86.1K- 82.88% |
$86.1K - $189K
|
17.8K
$24.9K
|
|
|
Aug 09, 2024
Q2 2024
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-416K- 49.5% |
$416K - $916K
|
425K
$595K
|
|
|
Aug 14, 2024
Q2 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-542K- 82.37% |
$542K - $1.19M
|
116K
$162K
|
|
|
Aug 14, 2024
Q2 2024
|
Laurion Capital Management LP
New York, NY |
SELL
|
- |
-657K- 20.66% |
$657K - $1.45M
|
2.53M
$3.54M
|
|
|
Aug 13, 2024
Q2 2024
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-1.75M- 77.86% |
$1.75M - $3.85M
|
498K
$697K
|